Piramal Enterprises Limited (PEL.NS)
INR 1115.7
(-2.78%)
INR 1115.7
(-2.78%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 60.33 Billion INR | 26.09% |
| 2022 | 47.85 Billion INR | -65.4% |
| 2021 | 138.29 Billion INR | 8.29% |
| 2020 | 127.7 Billion INR | -1.53% |
| 2019 | 129.69 Billion INR | -1.29% |
| 2018 | 131.38 Billion INR | 24.27% |
| 2017 | 105.72 Billion INR | 25.3% |
| 2016 | 84.38 Billion INR | 28.14% |
| 2015 | 65.85 Billion INR | 29.22% |
| 2014 | 50.96 Billion INR | 14.15% |
| 2013 | 44.64 Billion INR | 27.7% |
| 2012 | 34.95 Billion INR | 63.9% |
| 2011 | 21.32 Billion INR | -15.02% |
| 2010 | 25.09 Billion INR | -30.75% |
| 2009 | 36.24 Billion INR | 11.7% |
| 2008 | 32.44 Billion INR | 13.92% |
| 2007 | 28.48 Billion INR | 17.69% |
| 2006 | 24.2 Billion INR | 52.93% |
| 2005 | 15.82 Billion INR | 20.97% |
| 2004 | 13.08 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 21.82 Billion INR | 40.19% |
| 2024 Q1 | 15.56 Billion INR | 1321.38% |
| 2023 Q1 | 18.93 Billion INR | 949.05% |
| 2023 FY | 60.33 Billion INR | 26.09% |
| 2023 Q3 | 21.11 Billion INR | 9.37% |
| 2023 Q2 | 19.3 Billion INR | 1.94% |
| 2023 Q4 | 1.09 Billion INR | -94.81% |
| 2022 Q3 | 20.93 Billion INR | 10.57% |
| 2022 FY | 47.85 Billion INR | -65.4% |
| 2022 Q1 | 35.48 Billion INR | -11.27% |
| 2022 Q2 | 18.93 Billion INR | -46.63% |
| 2022 Q4 | 1.8 Billion INR | -91.38% |
| 2021 FY | 138.29 Billion INR | 8.29% |
| 2021 Q3 | 38.16 Billion INR | 22.88% |
| 2021 Q1 | 29.08 Billion INR | -13.51% |
| 2021 Q4 | 39.98 Billion INR | 4.79% |
| 2021 Q2 | 31.05 Billion INR | 6.77% |
| 2020 Q4 | 33.62 Billion INR | 6.13% |
| 2020 FY | 127.7 Billion INR | -1.53% |
| 2020 Q1 | 29.37 Billion INR | 43.02% |
| 2020 Q2 | 33.01 Billion INR | 12.41% |
| 2020 Q3 | 31.68 Billion INR | -4.04% |
| 2019 Q3 | 38.05 Billion INR | 5.61% |
| 2019 FY | 129.69 Billion INR | -1.29% |
| 2019 Q2 | 36.03 Billion INR | 2.78% |
| 2019 Q4 | 20.53 Billion INR | -46.03% |
| 2019 Q1 | 35.06 Billion INR | -2.69% |
| 2018 FY | 131.38 Billion INR | 24.27% |
| 2018 Q2 | 31.44 Billion INR | 8.32% |
| 2018 Q1 | 29.02 Billion INR | -2.96% |
| 2018 Q4 | 36.03 Billion INR | 3.27% |
| 2018 Q3 | 34.89 Billion INR | 10.97% |
| 2017 FY | 105.72 Billion INR | 25.3% |
| 2017 Q4 | 29.91 Billion INR | 4.64% |
| 2017 Q3 | 28.58 Billion INR | 12.72% |
| 2017 Q2 | 25.35 Billion INR | 12.92% |
| 2017 Q1 | 22.45 Billion INR | -8.37% |
| 2016 FY | 84.38 Billion INR | 28.14% |
| 2016 Q4 | 24.5 Billion INR | 5.93% |
| 2016 Q3 | 23.13 Billion INR | 19.49% |
| 2016 Q2 | 19.36 Billion INR | 9.96% |
| 2016 Q1 | 17.61 Billion INR | 4.78% |
| 2015 Q4 | 16.8 Billion INR | -9.04% |
| 2015 Q1 | 14.62 Billion INR | 11.26% |
| 2015 Q2 | 15.33 Billion INR | 4.84% |
| 2015 Q3 | 18.47 Billion INR | 20.49% |
| 2015 FY | 65.85 Billion INR | 29.22% |
| 2014 Q1 | 11.66 Billion INR | 3.55% |
| 2014 Q4 | 13.14 Billion INR | -4.83% |
| 2014 Q2 | 12.24 Billion INR | 5.03% |
| 2014 FY | 50.96 Billion INR | 14.15% |
| 2014 Q3 | 13.81 Billion INR | 12.79% |
| 2013 Q1 | 9.58 Billion INR | 3.4% |
| 2013 FY | 44.64 Billion INR | 27.7% |
| 2013 Q4 | 11.26 Billion INR | -11.28% |
| 2013 Q3 | 12.69 Billion INR | 14.31% |
| 2013 Q2 | 11.1 Billion INR | 15.86% |
| 2012 Q4 | 9.26 Billion INR | -5.6% |
| 2012 Q2 | 8.5 Billion INR | 15.53% |
| 2012 Q1 | 7.36 Billion INR | 12.13% |
| 2012 Q3 | 9.81 Billion INR | 15.42% |
| 2012 FY | 34.95 Billion INR | 63.9% |
| 2011 Q3 | 5.6 Billion INR | 0.0% |
| 2011 FY | 21.32 Billion INR | -15.02% |
| 2011 Q4 | 6.56 Billion INR | 17.2% |
| 2010 FY | 25.09 Billion INR | -30.75% |
| 2009 FY | 36.24 Billion INR | 11.7% |
| 2008 FY | 32.44 Billion INR | 13.92% |
| 2007 FY | 28.48 Billion INR | 17.69% |
| 2006 FY | 24.2 Billion INR | 52.93% |
| 2005 FY | 15.82 Billion INR | 20.97% |
| 2004 FY | 13.08 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Sigachi Industries Limited | 3.98 Billion INR | -1412.379% |
| Ind-Swift Limited | 5.02 Billion INR | -1100.819% |
| Bajaj HealthCare Limited | 4.73 Billion INR | -1174.504% |
| Sakar Healthcare Limited | 1.54 Billion INR | -3813.755% |
| Aurobindo Pharma Limited | 290.01 Billion INR | 79.195% |
| Innova Captab Limited | 10.81 Billion INR | -458.004% |
| Divi's Laboratories Limited | 78.45 Billion INR | 23.088% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | -365.734% |
| Morepen Laboratories Limited | 17.01 Billion INR | -254.529% |
| Mankind Pharma Limited | 103.34 Billion INR | 41.617% |
| Sequent Scientific Limited | 13.69 Billion INR | -340.505% |
| Wanbury Limited | 5.75 Billion INR | -948.16% |
| Laurus Labs Limited | 50.01 Billion INR | -20.631% |
| Nectar Lifesciences Limited | 16.84 Billion INR | -258.176% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | -164.265% |
| Alembic Limited | 1.57 Billion INR | -3731.297% |
| Hikal Limited | 17.84 Billion INR | -238.1% |
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | 1.282% |
| Neuland Laboratories Limited | 15.58 Billion INR | -287.13% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.47 Billion INR | -75.009% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | 48.923% |
| IOL Chemicals and Pharmaceuticals Limited | 21.32 Billion INR | -182.903% |
| Themis Medicare Limited | 3.81 Billion INR | -1480.5% |
| RPG Life Sciences Limited | 5.82 Billion INR | -936.634% |
| Zydus Lifesciences Limited | 190.21 Billion INR | 68.279% |
| Lupin Limited | 196.56 Billion INR | 69.304% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | -1332.406% |
| Wockhardt Limited | 27.89 Billion INR | -116.34% |
| Vaishali Pharma Limited | 862.79 Million INR | -6893.221% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | -232.344% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -2791.074% |
| Jubilant Pharmova Limited | 67.02 Billion INR | 9.983% |
| FDC Limited | 19.42 Billion INR | -210.546% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 78.386% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -3808.552% |
| Eris Lifesciences Limited | 20.09 Billion INR | -200.314% |
| Venus Remedies Limited | 5.91 Billion INR | -920.16% |
| ZIM Laboratories Limited | 3.67 Billion INR | -1541.755% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | -683.352% |
| Par Drugs and Chemicals Limited | 956.4 Million INR | -6208.767% |
| Caplin Point Laboratories Limited | 16.76 Billion INR | -259.84% |
| Shilpa Medicare Limited | 11.53 Billion INR | -423.259% |
| Albert David Limited | 3.62 Billion INR | -1564.653% |
| Ajanta Pharma Limited | 42.08 Billion INR | -43.363% |
| Hester Biosciences Limited | 3.04 Billion INR | -1881.221% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | -473.901% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | -387.224% |
| Gufic Biosciences Limited | 8.06 Billion INR | -647.984% |
| Windlas Biotech Limited | 6.3 Billion INR | -856.284% |
| Procter & Gamble Health Limited | 11.51 Billion INR | -424.098% |
| Aarey Drugs & Pharmaceuticals Limited | 3.95 Billion INR | -1425.141% |
| Mangalam Drugs & Organics Limited | 3.67 Billion INR | -1542.486% |
| Granules India Limited | 45.06 Billion INR | -33.893% |
| Aarti Drugs Limited | 25.28 Billion INR | -138.622% |
| Bal Pharma Limited | 3.39 Billion INR | -1678.709% |
| Alkem Laboratories Limited | 126.67 Billion INR | 52.369% |
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 87.559% |
| Lincoln Pharmaceuticals Limited | 5.8 Billion INR | -939.313% |
| Medicamen Biotech Limited | 1.79 Billion INR | -3265.043% |
| Unichem Laboratories Limited | 16.57 Billion INR | -264.044% |
| Bafna Pharmaceuticals Limited | 1.52 Billion INR | -3857.434% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -14971.025% |
| Valiant Laboratories Limited | 1.82 Billion INR | -3214.195% |
| Orchid Pharma Limited | 8.19 Billion INR | -636.388% |
| Medico Remedies Limited | 1.44 Billion INR | -4063.47% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | -371.054% |
| Ipca Laboratories Limited | 77.05 Billion INR | 21.7% |
| Brooks Laboratories Limited | 794.86 Million INR | -7490.925% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -2227.433% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | 43.107% |
| NATCO Pharma Limited | 40.02 Billion INR | -50.768% |
| Suven Life Sciences Limited | 116.92 Million INR | -51501.656% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -11866.582% |
| Strides Pharma Science Limited | 40.51 Billion INR | -48.94% |
| Indoco Remedies Limited | 18.17 Billion INR | -232.018% |
| Alpa Laboratories Limited | 1.08 Billion INR | -5448.819% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -5683.035% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -7886.903% |